Understanding physician perspectives on scientific meetings, how meetings are changing and future challenges for pharma companies.
As part of their overall learning journey, healthcare professionals (HCPs) attend scientific meetings to expand their knowledge, connect with peers, listen to thought-leaders and discuss new advances in treatment.
Surveys consistently reveal that scientific meetings feature in the top three preferred channels for HCP medical education. But will that always be the case?
With changes in legislation and shifts in technology that facilitate remote learning, will HCPs continue to travel halfway around the globe for a scientific meeting, advisory board or standalone meeting, taking precious days away from their practice?
Or will they become increasingly selective, looking for alternative medical education channels and only attending meetings in person known to deliver a return on their objectives and time?
These questions point to trends which look set to continue for the foreseeable future.
Our aim has been to find out what drives HCPs to attend scientific meetings, what criteria they use in evaluating their value, and how they see the scientific meetings of the future evolving.
Download this white paper to further understand the research and analysis we conducted and how you can engage with HCPs effectively when looking at the future of meetings.